- Home
- SPEG vs ZNTL Comparison
SPEG vs ZNTL Comparison
Compare SPEG & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.45
Company Overview
Basic Information| Metric | SPEG | ZNTL |
|---|---|---|
| Founded | 2024 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.3M | 152.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPEG | ZNTL |
|---|---|---|
| Price | $10.13 | $2.45 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.60 |
| AVG Volume (30 Days) | 18.0K | ★ 584.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.87 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,425,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.95 | $1.01 |
| 52 Week High | $11.03 | $3.95 |
Technical Indicators
Market Signals| Indicator | SPEG | ZNTL |
|---|---|---|
| Relative Strength Index (RSI) | 64.45 | 52.73 |
| Support Level | $10.11 | $2.32 |
| Resistance Level | $10.15 | $2.69 |
| Average True Range (ATR) | 0.00 | 0.22 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 50.00 | 51.56 |
Price Performance
Historical Comparison SPEG
ZNTL
About SPEG Silver Pegasus Acquisition Corp Class A Ordinary Shares
Silver Pegasus Acquisition Corp is a blank check company.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.